Anti-CTLA-4 nano antibody, coding gene, recombinant nano antibody, recombinant vector, recombinant bacterium and application thereof

A technology of CTLA-4 and nanobody, which is applied in the field of immunology, can solve the problem of no nanobody report

Active Publication Date: 2022-05-06
GUANGDONG MEDICAL UNIV +1
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] No nanobodies targeting CTLA-4 have been reported so far

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-CTLA-4 nano antibody, coding gene, recombinant nano antibody, recombinant vector, recombinant bacterium and application thereof
  • Anti-CTLA-4 nano antibody, coding gene, recombinant nano antibody, recombinant vector, recombinant bacterium and application thereof
  • Anti-CTLA-4 nano antibody, coding gene, recombinant nano antibody, recombinant vector, recombinant bacterium and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0073] For the construction of natural camel-derived nanobody gene library:

[0074] Extract total RNA from camel spleen tissue, the specific steps are as follows:

[0075] ①Take out camel spleen tissue from -80°C, add liquid nitrogen to crush the sample specimen, add 1ml Trizol for every 100mg of ground tissue, and homogenize with a glass homogenizer until no tissue sample particles can be seen with the naked eye. Then transfer it to a 1.5ml centrifuge tube and let it stand at room temperature for 15 minutes.

[0076] ②According to the ratio of adding 0.2ml chloroform to every 1ml Trizol, shake vigorously for 15s, and let stand at room temperature for 3min.

[0077] ③Centrifuge the sample at 12000rpm at 4°C for 15min, and transfer the upper layer to a new Ep tube.

[0078] ④Add an equal volume of isopropanol and mix on ice for 20min.

[0079] ⑤ Centrifuge the solution at 12,000 rpm at 4°C for 10 min, and discard the supernatant.

[0080] ⑥ Add 75% ethanol prepared with 1m...

Embodiment 2

[0127] Expression and purification of nanobodies in host bacteria Escherichia coli:

[0128] (1) Ligate the Nanobody sequence obtained by sequencing analysis to the human IgG Fc segment and subclone it into the pCZN1 plasmid vector, and transform it into Escherichia coli Arctic Express. Pick a single clone on the transformation plate and inoculate it in a medium containing 50 μg / mLAmp In a test tube of 3mL LB culture solution, shake overnight at 37°C at 220rpm; (2) inoculate in 30mL LB culture solution of 50μg / mL Amp at 1:100 the next day, shake at 37°C at 220rpm until the cell OD600 is 0.6-0.8, add IPTG to a final concentration of 0.5mM, shake overnight at 20°C and 220rpm to induce expression of the fusion protein; (3) collect the bacteria and perform ultrasonic disruption to obtain a bold liquid of the inclusion body protein, which is then affinity-purified by a Ni column to obtain the fusion protein. Figure 4 It is the westernblot diagram of the purified anti-CTLA-4 nanobo...

Embodiment 3

[0130] Specificity verification of anti-CTLA-4 nanobody D11:

[0131] The CTLA-4 antigen and activated human T cells were used for western blot (the primary antibody was purified anti-CTLA-4 nanobody D11, and the secondary antibody was anti-human IgG Fc / HRP). Figure 5 Middle lane 1 is the whole protein of activated human T cells, lane 2 is the whole protein of 293T cells without CTLA-4 expression, and lane 3 is the CTLA-4 antigen. This shows that the anti-CTLA-4 nanobody D11 provided by the present invention can specifically recognize the CTLA-4 antigen.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
affinityaaaaaaaaaa
Login to view more

Abstract

The invention provides an anti-CTLA-4 nano antibody, a coding gene, a recombinant nano antibody, a recombinant vector, recombinant bacteria and application thereof, and belongs to the technical field of immunology. The anti-CTLA-4 nano antibody D11 disclosed by the invention is designed aiming at a heavy chain of CTLA-4, and the anti-CTLA-4 nano antibody D11 comprises a framework region FR and an antigenic determinant complementary CDR. The nano antibody D11 provided by the invention can specifically recognize a CTLA-4 antigen. According to the present invention, the coding gene for coding the anti-CTLA-4 nanometer antibody D11 and the human IgG Fc segment gene are subjected to fusion expression to obtain the recombinant nanometer antibody, and the recombinant nanometer antibody can specifically recognize the CTLA-4 antigen, and can be used for tumor molecular diagnosis and / or antitumor drug preparation.

Description

technical field [0001] The invention belongs to the technical field of immunology, and specifically relates to an anti-CTLA-4 nanobody, a coding gene, a recombinant nanobody, a recombinant carrier, a recombinant bacterium and applications thereof. Background technique [0002] Cytotoxic T lymphocyte associated protein-4 (CTLA-4) is another immunosuppressive receptor expressed on T cells, which binds to B7 molecules to induce T cell anergy and participate in immune response Negative regulation of responses. Blocking CTLA-4 molecules can improve the anti-tumor response of T cells and kill tumor cells. [0003] Nanobodies were first reported by Belgian scientists in Nature in 1993. They are a natural light-chain-deficient antibody (VHH) that exists in the peripheral blood of alpacas. Found in fish, it is currently known as the smallest unit that can bind target antigens. The molecular weight of VHH is only 15KD, so it is also called nanobody (Nanobody, Nb). Nanobodies have ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07K16/28C12N15/13C12N15/70C12N1/21G01N33/68G01N33/574A61K39/395A61P35/00C12R1/19
CPCC07K16/2818C12N15/70G01N33/574G01N33/68A61P35/00C07K2317/569C07K2317/52A61K2039/505Y02A50/30
Inventor 徐广贤张艳婷张爱君蒋丹王丽燕李艳宁
Owner GUANGDONG MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap